Imagindairy unveils industrial-scale manufacturing of its milk protein in newly owned 100,000 liter production lines

Imagindairy, the Israeli-based food tech startup producing sustainable, animal-free dairy proteins that are equally as delicious and nutritious as those from bovine sources, has announced that it has acquired and is operating its own industrial-scale precision fermentation production lines focused on the production of dairy ingredients. Imagindairy has become the first company in the industry to achieve this milestone, fully owning and operating its own industrial-scale production lines dedicated solely to animal-free milk proteins. This news, combined with the startup's advanced technology, puts Imagindairy in a position to offer animal-free products at cost parity to traditional dairy.

"Having just entered the landscape three years ago, this achievement is a big step forward for us," said Dr Eyal Afergan, Imagindairy Co-founder & CEO. "We've overcome industry-wide hurdles that have previously been holding precision fermentation dairy back, including the production capacity bottleneck and ensuring that unit economics make sense across the supply chain. This will enable our customers to put animal-free dairy products on-shelf at cost parity to traditional dairy, without compromising on quality. It's a substantial breakthrough and important step that will allow us to support mass-market adoption, transition to an industrial company, and speed up the development of other milk proteins."

The facility allows Imagindairy access to production at more than 100,000 liters of fermentation capacity, with planned capacity expansion to triple this volume in the next one to two years. At present, Imagindairy is already producing industrial-scale batches in the facility at a competitive cost structure to traditional dairy.

This achievement comes on the heels of another major company milestone, as Imagindairy received a 'no questions' response letter from the US Food & Drug Administration (FDA) last month for the Generally Recognized as Safe (GRAS) notice submitted by the company. This signifies that the ingredient is safe to be used in food and beverage products, providing a regulatory 'green light' for food and beverage manufacturers to partner with Imagindairy. The Israeli food-tech can now offer the most efficient manufacturing and end-to-end capabilities, extending through in-market product availability.

"We've always been passionate about investing in transformational technologies that support the planet and its people," added Shmuel Chafets, Founder & Partner at Target Global, an investment firm that has backed Imagindairy since 2022. "Imagindairy is paving an entirely new future for the dairy industry, and these two great achievements demonstrate what that future will look like."

"Imagindairy has an inherent culture of capital efficiency and achieving more with less," added Jonathan Berger, CEO of The Kitchen FoodTech Hub. "As the earliest supporter of the company, we know it has the right technology and the right team to disrupt the dairy industry."